Eton Pharmaceuticals, Inc. Cash and Cash Equivalents, Period Increase (Decrease)
Eton Pharmaceuticals, Inc. (ETON) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$7.15 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-07.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-05-07
- Eton Pharmaceuticals, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was -$7.15M.
- Eton Pharmaceuticals, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was $20.13M.
- Eton Pharmaceuticals, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-03-31 was -$1.94M.
- Eton Pharmaceuticals, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2018 was $13.58M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 5 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 8 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|---|---|
| 2019-03-31 | -$7.15M 10-Q · filed 2019-05-07 | $12.98M derived: sum of 2 quarters · filed 2019-05-07 | ||||
| 2018-12-31 | $20.13M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | $13.58M 10-K · filed 2019-03-25 | ||||
| 2018-09-30 | -$6.55M 10-Q · filed 2018-12-20 | |||||
| 2018-03-31 | -$1.94M 10-Q · filed 2019-05-07 | |||||
| 2017-12-31 | $13.16M 10-K · filed 2019-03-25 | |||||
| 2017-09-30 | $14.23M 10-Q · filed 2018-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |